These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 4175962)

  • 21. Antigenic complexity of Treponema pallidum: antigenicity and surface localization of major polypeptides.
    Norris SJ; Sell S
    J Immunol; 1984 Nov; 133(5):2686-92. PubMed ID: 6207241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on the chemical composition and immunologic properties of a polysaccharide from the Reiter treponeme.
    Nell EE; Hardy PH
    Immunochemistry; 1966 May; 3(3):233-45. PubMed ID: 4959591
    [No Abstract]   [Full Text] [Related]  

  • 23. [Production and control of Reiter treponema antigen].
    Surján L; Jaszovszky S; Füst G; Pusztai Z
    Orv Hetil; 1970 Nov; 111(45):2655-7. PubMed ID: 4923176
    [No Abstract]   [Full Text] [Related]  

  • 24. [INHIBITION OF THE TREPONEMICIDE POWER OF ANTI-REITER SERUM BY HOMOLOGOUS POLYSACCHARIDE].
    DICHIARA G; TRINGALI G; BUTTITTA C; ZAFFIRO P
    Riv Ist Sieroter Ital; 1964; 39():470-6. PubMed ID: 14259055
    [No Abstract]   [Full Text] [Related]  

  • 25. [Syphilis. Current physiobiological data. I. The bacteriological problem].
    Collart P; Poitevin M
    Sem Hop; 1981 May 8-15; 57(17-18):857-68. PubMed ID: 6262923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [COMPARISON OF THE ANTIGENIC STRUCTURES OF 2 STRAINS OF KAZAN'S TREPONEMA (STRAINS NO. V AND NO. V.K-1B) AND OF REITER'S TREPONEMA].
    DUPOUEY P
    Rev Immunol Ther Antimicrob; 1963; 27():347-56. PubMed ID: 14116075
    [No Abstract]   [Full Text] [Related]  

  • 27. [The significance of the complement fixation test with protein fraction of Treponema pallidum (TPCF) for serodiagnosis of syphilis].
    Butovetskiĭ LD; Kaĭkina BG
    Vestn Dermatol Venerol; 1966 Nov; 40(11):52-7. PubMed ID: 4886611
    [No Abstract]   [Full Text] [Related]  

  • 28. The role of protein component of T. pallidum in inducing skin reaction for delayed hypersensitivity.
    Podwińska J
    Arch Immunol Ther Exp (Warsz); 1983; 31(6):887-93. PubMed ID: 6378135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Humoral immune response in human syphilis to polypeptides of Treponema pallidum.
    Hanff PA; Fehniger TE; Miller JN; Lovett MA
    J Immunol; 1982 Sep; 129(3):1287-91. PubMed ID: 7050242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Contribution to serological differentiation of pathogenic and non-pathogenic Treponema].
    Moser L
    Zentralbl Bakteriol Orig; 1964 Jul; 193(3):375-86. PubMed ID: 5319204
    [No Abstract]   [Full Text] [Related]  

  • 31. [RPCF test].
    Osada F
    Rinsho Byori; 1968 Apr; 16(4):348-53. PubMed ID: 4880299
    [No Abstract]   [Full Text] [Related]  

  • 32. Antigenic characteristics of nucleic acids of cultivable treponemes.
    Király K; Jobbágy A
    Z Immunitatsforsch Allerg Klin Immunol; 1966 Dec; 131(5):434-43. PubMed ID: 4231189
    [No Abstract]   [Full Text] [Related]  

  • 33. [Antigenic composition of Treponema. II. Study of the crossed Treponema pallidum-Reiter's Treponema reaction with the aid of the complement fixation reaction and gel precipitation reaction].
    PILLOT J; DUPOUEY P; FAURE M
    Ann Inst Pasteur (Paris); 1960 May; 98():734-47. PubMed ID: 14433005
    [No Abstract]   [Full Text] [Related]  

  • 34. [Antigenic properties of certain strains of pure cultures of Treponema pallidum following complement fixation reaction with immune sera and with sera from syphilitic patients].
    ZEBNITSKAIA LV
    Vestn Venerol Dermatol; 1955; (No 4):24-7. PubMed ID: 13291722
    [No Abstract]   [Full Text] [Related]  

  • 35. [Seroreaction and pathogenic Treponema pallidum].
    Tomizawa T
    Rinsho Byori; 1972 Feb; 20(2):119-22. PubMed ID: 4555054
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunity in experimental syphilis. V. The immunogenicity of Treponema pallidum attenuated by gamma-irradiation.
    Miller JN
    J Immunol; 1967 Nov; 99(5):1012-6. PubMed ID: 4863764
    [No Abstract]   [Full Text] [Related]  

  • 37. [Intracellular complement fixation by "in vitro" stimulated lymphocytes (fluorescent serologic demonstration)].
    Heitmann HJ
    Z Haut Geschlechtskr; 1969 Feb; 44(4):121-4. PubMed ID: 4902560
    [No Abstract]   [Full Text] [Related]  

  • 38. Surface-associated antigens of Treponema pallidum concealed by an inert outer layer.
    Penn CW; Rhodes JG
    Immunology; 1982 May; 46(1):9-16. PubMed ID: 7042552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies of the mechanism of development of agglutinability of pathogenic Treponema pallidum. 3. Changes in the activity of different antigenic components to agglutinating antibodies.
    Metzger M; Podwińska J
    Arch Immunol Ther Exp (Warsz); 1967; 15(1):34-41. PubMed ID: 4860419
    [No Abstract]   [Full Text] [Related]  

  • 40. [Proteinic antigens of Treponema: demonstration of an antigen common to pathogenic Treponema and to the Reiter's protein of culturable Treponema].
    DARDANONI L; CENSUALES S
    Riv Ist Sieroter Ital; 1957; 32(6):489-500. PubMed ID: 13528679
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.